The store will not work correctly when cookies are disabled.
3-Hydroxy-1-methyl-5-((methyl(phenyl)amino)methyl)-1H-pyrazole-4-carboxylic acid
ID: ALA4451149
PubChem CID: 155522278
Max Phase: Preclinical
Molecular Formula: C13H15N3O3
Molecular Weight: 261.28
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: CN(Cc1c(C(=O)O)c(O)nn1C)c1ccccc1
Standard InChI: InChI=1S/C13H15N3O3/c1-15(9-6-4-3-5-7-9)8-10-11(13(18)19)12(17)14-16(10)2/h3-7H,8H2,1-2H3,(H,14,17)(H,18,19)
Standard InChI Key: WKFNJMDGGOCESI-UHFFFAOYSA-N
Molfile:
RDKit 2D
19 20 0 0 0 0 0 0 0 0999 V2000
31.8630 -10.6941 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.5260 -10.2162 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.2716 -9.4353 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.4544 -9.4353 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2000 -10.2162 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.9778 -9.0241 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.9747 -8.2069 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
30.9743 -8.7740 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
33.6870 -9.4300 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
33.3028 -10.4699 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.4715 -11.2694 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.2483 -11.5231 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8634 -11.8153 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.8630 -11.5113 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.4132 -12.3205 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.1892 -12.5743 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.7982 -12.0281 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.6260 -11.2249 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.8503 -10.9749 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4 5 2 0
2 3 2 0
1 2 1 0
3 4 1 0
5 1 1 0
3 6 1 0
6 7 2 0
4 8 1 0
6 9 1 0
2 10 1 0
10 11 1 0
11 12 1 0
11 13 1 0
1 14 1 0
12 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 12 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 261.28 | Molecular Weight (Monoisotopic): 261.1113 | AlogP: 1.46 | #Rotatable Bonds: 4 |
Polar Surface Area: 78.59 | Molecular Species: ACID | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 3.07 | CX Basic pKa: 1.45 | CX LogP: 2.60 | CX LogD: -2.10 |
Aromatic Rings: 2 | Heavy Atoms: 19 | QED Weighted: 0.87 | Np Likeness Score: -1.03 |
References
1. Pippione AC, Sainas S, Goyal P, Fritzson I, Cassiano GC, Giraudo A, Giorgis M, Tavella TA, Bagnati R, Rolando B, Caing-Carlsson R, Costa FTM, Andrade CH, Al-Karadaghi S, Boschi D, Friemann R, Lolli ML.. (2019) Hydroxyazole scaffold-based Plasmodium falciparum dihydroorotate dehydrogenase inhibitors: Synthesis, biological evaluation and X-ray structural studies., 163 [PMID:30529545] [10.1016/j.ejmech.2018.11.044] |